Skip to main content

8 Result(s)

within Lin Run Wang Remove this filter

and

  1. No Access

    Article

    Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy

    To investigate the correlation between protein expression of breast cancer susceptibility gene 1 (BRCA1) and topoisomerase IIβ-binding protein 1 (TopBP1) and clinical outcome of non-small cell lung cancer treated...

    Lin-run Wang, Lin-Juan He, Yang Wang, Yin-yan Li… in Cancer Chemotherapy and Pharmacology (2015)

  2. Article

    Open Access

    The role of quality control circles in sustained improvement of medical quality

    We used quality control circles (QCC) followed by the PDCA Deming cycle and analyzed the application of QCC to the sustained improvement of a medical institution in Zhejiang province. Analyses of the tangible ...

    Lin-run Wang, Yang Wang, Yan Lou, Ying Li, **ng-guo Zhang in SpringerPlus (2013)

    Download PDF (253 KB) View Article

  3. No Access

    Article

    XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies

    XRCC1 polymorphism is a research hotpot in individual treatment for non-small cell lung cancer (NSCLC). To obtain the association between XRCC1 polymorphism and clinical outcome of pla...

    Jian Chen, Qing-wei Zhao, Gen-ming Shi… in Journal of Zhejiang University SCIENCE B (2012)

  4. No Access

    Article

    RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer

    To comparatively evaluate the prognostic or predictive value of ribonucleotide reductase M1 (RRM1) and excision repair cross-complementation 1 (ERCC1) gene expression in peripheral blood versus tumor tissue fr...

    Guo Bing Zhang, Jian Chen, Lin Run Wang, Jun Li… in Cancer Chemotherapy and Pharmacology (2012)

  5. No Access

    Article

    RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum

    To evaluate the predictive values of gene expressions of ribonucleotide reductase M1 (RRM1) and breast cancer susceptibility gene 1 (BRCA1) in peripheral blood from Chinese patients with non-small-cell lung cance...

    Lin-run Wang, Guo-bing Zhang, Jian Chen, Jun Li… in Journal of Zhejiang University SCIENCE B (2011)

  6. No Access

    Article

    Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

    To evaluate the efficacy and safety of gemcitabine in combination with carboplatin at standard rate or fixed dose rate infusion in patients with advanced non-small-cell lung cancer (NSCLC).

    Lin Run Wang, Ming Zhu Huang, Guo Bing Zhang… in Cancer Chemotherapy and Pharmacology (2007)

  7. No Access

    Article

    Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small-cell lung cancer

    To conduct a randomized comparative trial of pharmacokinetics, efficacy and toxicity profile treatment with 1200 mg/m2 gemcitabine using standard 30-min infusion or fixed dose rate (FDR) infusion [10 mg/(m2·min)]...

    Lin-run Wang, Jian Liu, Ming-zhu Huang, Nong Xu in Journal of Zhejiang University SCIENCE B (2007)

  8. No Access

    Article

    Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer

    To determine the pharmacokinetics of gemcitabine (2′,2′-difluorodeoxycytidine) in Chinese non-small-cell lung cancer (NSCLC) patients. Six study subjects were administered gemcitabine at a fixed dose rate of 1...

    Lin-run Wang, Ming-zhu Huang, Nong Xu… in Journal of Zhejiang University-SCIENCE B (2005)